The present invention provides a compound having p38 MAP kinase inhibitory activity. Because of having p38 MAP kinase inhibitory activity, the compounds represented by the formula (I):
wherein each symbol is as defined in the description, salts thereof, N-oxides thereof, solvates thereof, or prodrugs thereof are useful in preventing and/or treating diseases that are supposedly caused or deteriorated by abnormal production of cytokines including inflammatory cytokines or chemokines, or by overresponse thereto, namely cytokine-mediated diseases such as inflammatory diseases, respiratory diseases, cardiovascular diseases and bone diseases.
本发明提供了一种具有p38
MAP激酶抑制活性的化合物。由于具有p38
MAP激酶抑制活性,因此由式(I)表示的化合物:其中每个符号如描述中所定义的,其盐,N-氧化物,溶剂合物或前药在预防和/或治疗据称是由细胞因子异常产生或恶化引起的疾病中有用,包括炎症性细胞因子或
趋化因子,或由于对其过度反应而引起的,即细胞因子介导的疾病,例如炎症性疾病,呼吸系统疾病,心血管疾病和骨骼疾病。